Загрузка...
Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience
BACKGROUND: The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus. METHODS: We performed a retrospective analysis of 47 patients treated...
Сохранить в:
| Опубликовано в: : | World J Surg Oncol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217450/ https://ncbi.nlm.nih.gov/pubmed/28056988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1066-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|